This is a preview of subscription content, log in via an institution to check access.
Notes
six-monthly palpation and ultrasound, yearly mammography, and breast magnetic resonance imaging
2012−2014 euros
Reference
Muller D, et al. Cost-effectiveness of different strategies to prevent breast and ovarian cancer in German women with a BRCA 1 or 2 mutation. European Journal of Health Economics : 5 Apr 2017. Available from: URL: http://dx.doi.org/10.1007/s10198-017-0887-5
Rights and permissions
About this article
Cite this article
BRCA1/2: bilateral mastectomy plus BSO cost effective. PharmacoEcon Outcomes News 776, 6 (2017). https://doi.org/10.1007/s40274-017-3908-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-017-3908-9